Institutional development · Research, innovation and assessment · Libya
Benghazi researcher co-authors PLOS ONE protocol on metformin in gestational diabetes
Professor Mahmoud Werfalli of Libya's University of Benghazi is a co-author of an international study protocol, published in PLOS ONE, on metformin's anti-inflammatory effects in gestational diabetes.
Why it matters: The University of Benghazi counts a co-authorship in an international PLOS ONE protocol on metformin and gestational diabetes among its research outputs.
The University of Benghazi said Professor Mahmoud Werfalli, one of its researchers, has co-authored an international study protocol published in the journal PLOS ONE.
According to the university, the protocol sets out a study of the anti-inflammatory effects of metformin, a diabetes drug, in gestational diabetes.
The university said the study will use a systematic review and meta-analysis, methods that pool findings from existing research.
Editor’s view
Joseph Lopez, Collaboration Editor
The University of Benghazi reports that Professor Mahmoud Werfalli is a co-author of this international protocol, which describes a planned systematic review and meta-analysis of metformin's anti-inflammatory effects in gestational diabetes.